We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+2.84%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$37.8B
AUM Growth
+$858M
Cap. Flow
+$54.1M
Cap. Flow %
0.14%
Top 10 Hldgs %
5.01%
Holding
2,954
New
116
Increased
1,159
Reduced
1,473
Closed
125

Top Buys

Rank Stock Value
1
IT icon
Gartner
IT
+$57.5M
2
ALGN icon
Align Technology
ALGN
+$53.5M
3
DXC icon
DXC Technology
DXC
+$51.9M
4
ANSS
Ansys
ANSS
+$46.1M
5
EG icon
Everest Group
EG
+$34.5M

Sector Composition

Rank Sector Weight
1 Technology 13.9%
2 Financials 12.99%
3 Healthcare 12.28%
4 Industrials 11.03%
5 Consumer Discretionary 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASML icon
1051
ASML
ASML
$596B
$4.7M 0.01%
36,057
+9,956
+38% +$1.32M
INVH icon
1052
Invitation Homes
INVH
$17.9B
$4.7M 0.01%
217,133
-90,117
-29% -$1.94M
ABB
1053
DELISTED
ABB Ltd
ABB
$4.66M 0.01%
187,140
-42,906
-19% -$1.05M
MATV icon
1054
Mativ Holdings
MATV
$479M
$4.65M 0.01%
124,825
-10,180
-8% -$403K
SUN icon
1055
Sunoco
SUN
$14.4B
$4.64M 0.01%
151,444
+129,770
+599% +$3.87M
CNSL
1056
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$4.63M 0.01%
215,922
+63,896
+42% +$1.39M
EVT icon
1057
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.06B
$4.63M 0.01%
211,664
-40,567
-16% -$879K
NKTR icon
1058
Nektar Therapeutics
NKTR
$2.39B
$4.63M 0.01%
15,789
-285
-2% -$82.4K
PCQ
1059
Pimco California Municipal Income Fund
PCQ
$163M
$4.63M 0.01%
273,600
-33,241
-11% -$557K
DIAX
1060
DELISTED
Nuveen Dow 30SM Dynamic Overwrite Fund
DIAX
$4.62M 0.01%
279,595
+33,763
+14% +$546K
OCLR
1061
DELISTED
Oclaro Inc.
OCLR
$4.61M 0.01%
493,623
+450,489
+1,044% +$4.08M
R icon
1062
Ryder
R
$9.9B
$4.61M 0.01%
64,021
-497,173
-89% -$34.4M
BP icon
1063
BP
BP
$112B
$4.59M 0.01%
149,533
+8,155
+6% +$254K
SAGE
1064
DELISTED
Sage Therapeutics
SAGE
$4.58M 0.01%
57,529
-8,698
-13% -$629K
VMI icon
1065
Valmont Industries
VMI
$8.86B
$4.58M 0.01%
30,630
-2,164
-7% -$325K
PMO
1066
Franklin Municipal Opportunities Trust
PMO
$282M
$4.57M 0.01%
365,408
-45,944
-11% -$568K
SCI icon
1067
Service Corp International
SCI
$11.8B
$4.56M 0.01%
136,397
-1,091
-0.8% -$34.8K
MRC
1068
DELISTED
MRC Global
MRC
$4.56M 0.01%
276,105
-103,066
-27% -$1.89M
LGND icon
1069
Ligand Pharmaceuticals
LGND
$5.77B
$4.56M 0.01%
60,162
-117
-0.2% -$8.19K
LPNT
1070
DELISTED
LifePoint Health, Inc.
LPNT
$4.55M 0.01%
67,793
-37,072
-35% -$2.34M
ADNT icon
1071
Adient
ADNT
$1.69B
$4.55M 0.01%
69,608
-15,050
-18% -$1.02M
EXAS
1072
DELISTED
Exact Sciences
EXAS
$4.55M 0.01%
128,650
-22,052
-15% -$681K
MYJ
1073
DELISTED
Blackrock Muni Yield New Jersey Fund, Inc.
MYJ
$4.54M 0.01%
283,361
-3,451
-1% -$54.3K
WR
1074
DELISTED
Westar Energy Inc
WR
$4.54M 0.01%
85,623
+6,804
+9% +$360K
SUPN icon
1075
Supernus Pharmaceuticals
SUPN
$2.7B
$4.53M 0.01%
105,153
-5,574
-5% -$198K

Similar funds

Guggenheim Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Guggenheim Capital held 2,954 positions worth $37.8B, up 2.3% from $36.9B the previous quarter. Its ten largest holdings account for 5% of the portfolio.

Guggenheim Capital's Q2 2017 filing shows 116 new, 1,159 increased, 1,473 reduced and 125 closed positions. Its largest new stake was DXC Technology: 781,396 shares worth $51.9M. The largest sale was Yahoo Inc, an estimated $55.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q2 2017 buy was DXC Technology: 781,396 shares worth $51.9M.
  • Guggenheim Capital added most to Gartner in Q2 2017, an estimated $57.5M increase.
  • Guggenheim Capital's biggest Q2 2017 reduction was Teradata, cutting an estimated $40.2M.
  • Guggenheim Capital fully exited Yahoo Inc in Q2 2017, selling an estimated $55.8M.
  • Guggenheim Capital's ten largest holdings make up 5% of its $37.8B portfolio in Q2 2017.
  • Guggenheim Capital opened 116 new positions and closed 125 in Q2 2017.
  • Guggenheim Capital's portfolio value rose 2.3% quarter-over-quarter to $37.8B.

Based on Guggenheim Capital's 13F filing for Q2 2017, filed 14 Aug 2017.